Pharma Mar SA
Ms. Sanz is currently Director of the business area in the Legal Department of PharmaMar, a position she has held since July 2019. Ms. Sanz joined PharmaMar in 2007 as Legal Advisor, and in 2015 she was appointed as vice-secretary of the Board of Directors at PharmaMar. Previously, she was an Associate at the Elzaburu law firm. Ms. Sanz has a Law Degree from the Pontificia University of Comillas (ICADE E-1) and a Master’s Degree in Intellectual Property (Magister Lvcentinvs) from the University of Alicante.
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.